Evidence map›Paper›PMID 40455310›Full record

ArticleJournal of epidemiology and global health2025

The Precarious Future of HIV and AIDS Programs in Zimbabwe Following International Funding Freeze: Impact and Strategic Interventions.

Christopher Jimu

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Christopher JimuDiscipline of Psychology, University of Pretoria, Pretoria, South Africa. chrisjimu@gmail.com.ORCID http://orcid.org/0000-0001-9162-1934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few decades, significant progress has been made in the global fight against HIV and AIDS, largely driven by international funding mechanisms such as the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund. These initiatives have been instrumental in expanding access to antiretroviral therapy (ART), implementing prevention programs, and strengthening healthcare infrastructure, particularly in Sub-Saharan Africa (SSA), a region disproportionately affected by HIV. Zimbabwe, in particular, has achieved remarkable success in combating the epidemic, recently meeting the UNAIDS 95-95-95 fast-track targets, a testament to sustained international support and national commitment. However, the recent suspension of foreign aid, including funding for HIV programs, threatens to undermine these gains. For Zimbabwe, a prolonged freeze could lead to a resurgence of new infections, an increase in AIDS-related mortality, and further strain on Zimbabwe's already fragile healthcare system. This commentary examines the potential consequences of the aid suspension on Zimbabwe's HIV and AIDS response and explores strategies to mitigate its impact.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsInternational CooperationDelivery of Health CareHumansZimbabweFreezeHIV and AIDSInternational fundingUSAIDZimbabwe

Identifiers

PMID40455310
PMCPMC12130410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.